Within the recovery and performance community, few names come up as often as BPC-157. Let's look at what it actually is and what the available research does — and doesn't — say.
In short: BPC-157 is a pentadecapeptide studied mostly in animal models for its possible role in tissue repair and digestive health, without the same human clinical backing as an approved medication.
What is BPC-157?
BPC-157 is a pentadecapeptide (a 15-amino-acid chain) derived from a protein naturally found in gastric juice. That's where its full name comes from, “Body Protection Compound-157”. It has mainly been researched for its possible role in tissue repair.
What's researched about it
The areas most mentioned in the literature and in the community are:
- Tissue repair — tendons, ligaments, and muscle.
- Digestive health — consistent with its gastric origin.
- Post-injury recovery — one of the reasons it became popular in sports and gym culture.
Most of the available evidence on BPC-157 comes from preclinical studies (animal models). That doesn't invalidate the scientific interest, but it does mean there isn't the same level of human clinical evidence as with molecules approved as medications.
How it's typically administered
In the community, the reference protocol usually sits around 250 mcg, once or twice a day, subcutaneous. A typical vial comes in 5 mg and is reconstituted with about 3 mL of bacteriostatic water — but these figures are just a reference for what commonly circulates, not a medical recommendation.
What usually confuses beginners
Two things cause most of the confusion: first, the unit — BPC-157 vials usually come in mcg, not mg, and mixing up the two multiplies the error by a thousand. Second, the frequency — being a daily dose (not weekly, like GLP-1s), it's easy to lose track of whether you already applied it today without a record.
That's why, for a daily-use peptide like this one, it makes even more sense to keep a record of every application — in our reference protocols guide you can see typical values and calculate your dose in one click.
Sources
- Tendon, Ligament, and Muscle Injury Therapy Perspectives with BPC 157 — A Review — review of preclinical studies, not human trials
- The promoting effect of pentadecapeptide BPC 157 on tendon healing — animal model study
